Cited by 32Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

Variable Deposition of Amyloid β-Protein (Aβ) with the Carboxy-Terminus that Ends at Residue Valine40 (Aβ40) in the Cerebral Cortex of Patients with Alzheimer's Disease: A Double-Labeling Immunohistochemical Study with Antibodies Specific for Aβ40 and the Aβ that Ends at Residues Alanine42/Threonine43 (Aβ42)

Akiyama, Haruhiko, Mori, Hiroshi, Sahara, Naruhiko, Kondo, Hiromi, Ikeda, Kenji, Nishimura, Toru, Oda, Tatsuro, McGeer, Patrick L.·1997·Neurochemical Research

Abstract

Amyloid beta-protein (A beta) deposits in the cerebral cortices of patients with Alzheimer's disease (AD) were investigated immunohistochemically to determine their carboxy terminal sequences. Antibodies specific for A beta terminating at residue valine40 (A beta 40) and at residues alanine42/threonine43 (A beta 42) were used. Virtually all parenchymal A beta deposits were positive for A beta 42. Many of these deposits were also partially or completely labeled for A beta 40. The degree of A beta 40 labeling varied from area to area within a given brain and from AD case to AD case. In contrast to parenchymal deposits, A beta 40 labeled essentially all the vascular deposits which constitute amyloid angiopathy (AA), with A beta 42 occurring variably in some of these deposits. Occasional AA was found, however, in which A beta 42 predominated or was exclusively deposited. Such a diversity of A beta species, both in brain parenchyma and in AA, suggests that multiple C-terminal processing mechanisms occur in the cell types responsible for these deposits.

Integrity signals

Registry

Crossref · 10.1023/a:1021910729963

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Akiyama, H., Mori, H., Sahara, N., Kondo, H., Ikeda, K., Nishimura, T., Oda, T., & McGeer, P. L.
Affiliations
  • Tokyo Institute of Psychiatry (JP)
  • University of British Columbia (CA)
Corresponding author
Akiyama, Haruhiko
Venue
Neurochemical Research
Published
1997-12
Volume
22
Issue
12
Pages
1499-1506
ISSN
  • 0364-3190 (ISSN-L)
  • 1573-6903
OpenAlex
W1513148410
Cited by
32
References
4
Citations by year
2026: 1 · 2024: 1 · 2022: 2 · 2021: 2 · 2020: 4 · 2017: 3 · 2016: 2 · 2014: 1 · 2013: 1
FWCI
1.41
Type
journal article
Language
en
Open access
closed
Locations
  • Neurochemical Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
amyloid-beta, Aβ40, amyloid-beta 42, Alzheimer's disease, cerebral cortex, amyloid angiopathy, amyloid deposits, vascular amyloid deposits, antibody specificity
MeSH terms
Aged, Aged, 80 and over, Alanine, Alzheimer Disease, Antibodies, Antibody Specificity, Cerebral Cortex, Female, Humans, Immunohistochemistry, Male, Peptide Fragments, Staining and Labeling, Threonine, Valine, Amyloid beta-Peptides, Neurofibrillary Tangles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review